Colocalization of eQTLs With Type 2 Diabetes and Glycemic Traits Using Whole-Genome Sequences in Diverse Populations From the NHLBI Trans-Omics in Precision Medicine (TOPMed) Program
Diabetes · 01.08.2026 · 75 (8) · 1477-1491
DOI: 10.2337/db25-0557 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 11.06.2026. Verfasst von Ningyuan Wang und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Boston University School of Public Health, Boston, MA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Quantitative Trait Loci, Blood Glucose. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, NHGRI NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Large-scale multiancestry genome-wide association studies have identified hundreds of loci associated with type 2 diabetes (T2D) and glycemic traits, yet imputed genotyping arrays limit the detection of low-frequency and rare variants. Whole-genome sequencing (WGS) offers a more complete view of genetic variation, especially across diverse populations. We analyzed high-coverage (38×) WGS data from 21,913 T2D case subjects, 61,036 control subjects, and up to 50,011 individuals with no diabetes with fasting glucose, fasting insulin, and HbA1c from the National Heart, Lung, and Blood Institute Trans-Omics for Precision Medicine Program. We performed single-variant association testing, conditional analysis, fine-mapping, and Bayesian colocalization to identify genetic signals and assess regulatory relevance in diabetes-related tissues. We identified 76 distinct association signals across 34 loci, including novel variants at DUSP9 for T2D, and ROBO1, NDN, and MYT1 for HbA1c. Fine-mapping narrowed credible sets and improved causal variant resolution. Colocalization highlighted 80 expression signals in diabetes-related tissues, linking genetic associations to functional regulatory mechanisms. Our findings demonstrate the utility of WGS to uncover novel variants in diverse populations, enhance locus resolution, and link regulatory variation to disease-relevant tissues. This work refines the genetic architecture of T2D and glycemic traits and supports precision medicine efforts targeting diverse populations. Article Highlights We aimed to improve understanding of the genetic architecture of type 2 diabetes and glycemic traits by leveraging whole-genome sequencing in diverse populations. Our goal was to identify novel variants, refine known loci, and link genetic signals to regulatory mechanisms through colocalization with expression quantitative trait loci. We discovered novel variants, significantly improved fine-mapping resolution, and identified 80 regulatory colocalization signals in diabetes-relevant tissues. These findings support precision medicine approaches by connecting genetic variation to functional biology in type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biostatistics, Boston University School of Public Health, Boston, MA.
- Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
- Office of the Provost, University of South Carolina, Columbia, SC.
- Department of Epidemiology and Biostatistics, Arnold School of Public Health, Columbia, SC.
- Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
- Department of Human Genetics and South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX.
ORCID-Profile: April P Carson, Lifang Hou, Braxton D Mitchell, Stephen S Rich, Clary B Clish, James S Floyd, Robert E Gerzsten, Mark O Goodarzi, Rita R Kalyani, Simin Liu, Yongmei Liu
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
- NHGRI NIH HHS
- American Heart Association-American Stroke Association
- NCRR NIH HHS
- NIA NIH HHS
- WHI NIH HHS
- NINR NIH HHS
Zitieren
APA
Wang, N., DiCorpo, D. A., Zhang, Y., Kleinbrink, E., Arnett, D. K., Barnard, J., Blangero, J., Bowden, D. W., Carson, A. P., Chen, Y. I., Chung, M. K., Curran, J. E., Darbar, D., Duggirala, R., Ellinor, P. T., Fatkin, D., Fornage, M., Heard-Costa, N., He, J., …, & Liu, Y. (2026). Colocalization of eQTLs With Type 2 Diabetes and Glycemic Traits Using Whole-Genome Sequences in Diverse Populations From the NHLBI Trans-Omics in Precision Medicine (TOPMed) Program. Diabetes, 75(8), 1477-1491. https://doi.org/10.2337/db25-0557
Vancouver
Wang N, DiCorpo DA, Zhang Y, Kleinbrink E, Arnett DK, Barnard J, et al. Colocalization of eQTLs With Type 2 Diabetes and Glycemic Traits Using Whole-Genome Sequences in Diverse Populations From the NHLBI Trans-Omics in Precision Medicine (TOPMed) Program. Diabetes. 2026;75(8):1477-1491. doi:10.2337/db25-0557
BibTeX
@article{Wang2026,
author = {Wang, Ningyuan and DiCorpo, Daniel A and Zhang, Yixin and Kleinbrink, Erica and Arnett, Donna K and Barnard, John and Blangero, John and Bowden, Donald W and Carson, April P and Chen, Yii-Der Ida and Chung, Mina K and Curran, Joanne E and Darbar, Dawood and Duggirala, Ravindranath and Ellinor, Patrick T and Fatkin, Diane and Fornage, Myriam and Heard-Costa, Nancy and He, Jiang and Hou, Lifang and Kardia, Sharon L R and Kooperberg, Charles and Loos, Ruth J F and McManus, David D and Mitchell, Braxton D and Minster, Ryan L and North, Kari E and Psaty, Bruce M and Raffield, Laura M and Redline, Susan and Rich, Stephen S and Roden, Dan and Rotter, Jerome I and Shoemaker, Moore B and Smith, Jonathan D and Van Wagoner, David R and Aguet, Francois and Ardlie, Kristin and Bis, Joshua C and Brody, Jennifer A and Cade, Brian E and Clish, Clary B and de Vries, Paul S and Floyd, James S and Freedman, Barry I and Gabriel, Stacey and Gerzsten, Robert E and Goodarzi, Mark O and Gu, Charles and Guo, Xiuqing and Gupta, Namrata and Heckbert, Susan R and Hsu, Sarah and Hung, Yi-Jen and Kalyani, Rita R and Kelly, Tanika N and Kinney, Gregory L and Li, Changwei and Liu, Simin and Liu, Yongmei},
title = {Colocalization of eQTLs With Type 2 Diabetes and Glycemic Traits Using Whole-Genome Sequences in Diverse Populations From the NHLBI Trans-Omics in Precision Medicine (TOPMed) Program},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {8},
pages = {1477--1491},
doi = {10.2337/db25-0557}
}
EUVIMED